ISSN: 0973-7510

E-ISSN: 2581-690X

V.L. Jayasimha, K.G. Basavarajappa, K.V. Yogesh Babu, H.P. Niranjan and V. Vijayanath1
Department of Microbiology, ¹Department of Forensic Medicine & Toxicology, S.S.Institute of Medical Sciences & Research Centre, Davangere – 577 005, India
J Pure Appl Microbiol. 2011;5(1):381-385
© The Author(s). 2011
Received: 04/10/2010 | Accepted: 16/11/2010 | Published: 30/04/2011
Abstract

Dengue is a major health problem in many parts of the tropical world presenting as both epidemic & endemic forms. It is a mosquito borne illness caused by one of the serotypes of dengue viruses. Mortality rate of dengue in untreated patients is 10%-12%. The present study aims to determine whether the rapid test SD dengue duo (IgG, IgM, and NS-1 Ag detection) can be used as screening test in dengue outbreak when compared to ELISA. 226 serum samples were tested in patients clinically suspected Dengue. All the 226 samples were subjected to IgG, IgM Microlisa test. The same were put on rapid SD bioline Dengue duo rapid test and was compared with ELISA. 150 samples were tested positive with ELISA (either positive for IgG, IgM). When compared with ELISA, Rapid test showed sensitivity of 80.6% specificity and positive predictive value of 100% & zero false positive rates. Efficiency of the test was 87.16% SD Dengue duo rapid test should be a valuable screening test for dengue fever outbreak which can be interpreted easily. Results were comparable to ELISA. It provides additional diagnostic investigation of primary and secondary dengue that compliments NS-1 antigen detection.

Keywords

Dengue, ELISA, rapid test, NS-1 antigen

Article Metrics

Article View: 671

Share This Article

© The Author(s) 2011. Open Access. This article is distributed under the terms of the Creative Commons Attribution 4.0 International License which permits unrestricted use, sharing, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.